chrisvoncsefalvay/vaers-outcomes huggingface dataset:
8 wk old infant received vaccines on 6/17/11 at clinic - on 6/17/11 afternoon brought in clinic with fussiness, crying - cried several hours - unconsolable, (R) leg swollen from thigh to mid calf.
in late JAN93 exp lt-sided body numbness, numbness & weakness in lower extremities causing diff walking, & dec ability to urinate;also devel foot drop, weakness & tingling of hands, chronic fatigue, MS like illness;cognitive diff;
1 st dose: Red sore arm 2nd dose: fever, chills, body ache, head ache, loss of appetite
1)  Pain in joints hips and lower back _  tail bone area especially when sitting, shoulders and arms 2) Very Fatigued   3) Foggy Feeling in head, woozy   4)  Weakness in Legs especially when sitting and then very hard to stand up  5) After getting up and walking I get a burning sensation in my hip joints   6)  Shooting pain from my shoulders down  my arms and my hip joints down my legs when laying down at night   7) Taste isn't right       I have been taking a Prednisone Burst this has helped
Possible side-effect:  He has begun having low oxygen today (readings in the 80's).  He has shortness of breath.  He had a chest x-ray today and they said he has an enlarged heart, which he has never had before.
Pain in her arm; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer reported for herself that an 82-year-old female patient received the first dose of bnt162b2 (Pfizer-Biontech Covid-19 Vaccine), via an unspecified route of administration on 23Jan2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced pain in her arm on 23Jan2021 and was wondering if she could take Tylenol for this since she heard that you're not supposed to take it as it may interfere with the vaccine. Patient stated that she couldn't find any information on the sheet given to her whether she could take Tylenol or not after getting the vaccine. The outcome of the event was unknown.  Information about lot/batch number has been requested.
know if red and itching in her arm is normal; know if red and itching in her arm is normal; her left arm was red, swollen, hot and itchy; her left arm was red, swollen, hot and itchy; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (know if red and itching in her arm is normal), PRURITUS (know if red and itching in her arm is normal), PERIPHERAL SWELLING (her left arm was red, swollen, hot and itchy) and TENDERNESS (her left arm was red, swollen, hot and itchy) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (know if red and itching in her arm is normal), PRURITUS (know if red and itching in her arm is normal), PERIPHERAL SWELLING (her left arm was red, swollen, hot and itchy) and TENDERNESS (her left arm was red, swollen, hot and itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (know if red and itching in her arm is normal), PRURITUS (know if red and itching in her arm is normal), PERIPHERAL SWELLING (her left arm was red, swollen, hot and itchy) and TENDERNESS (her left arm was red, swollen, hot and itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Feb-2021: The outcome of events and treatment medication was provided by the reporter
a little bit of a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a little bit of a sore arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 031M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (a little bit of a sore arm). At the time of the report, PAIN IN EXTREMITY (a little bit of a sore arm) outcome was unknown.      Patient did not seek medical care for the event. Treatment information was not provided.   This case was linked to MOD-2022-556239, MOD-2022-555509, MOD-2022-556238 (Patient Link).
Pt recvd 2nd dose of vax on 2JAN92 & exp fever, flu-like sx, fever, nausea, abdo pain, muscle aches; pt did not receive 3rd dose of vax;
Arm is hurts at sight and down to fore arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is hurts at sight and down to fore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm is hurts at sight and down to fore arm). At the time of the report, PAIN IN EXTREMITY (Arm is hurts at sight and down to fore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported  Treatment medication information were not reported
Patient described left arm swelling, redness and rash.  No documentation found in medical folder that arm was evaluated by health care provider for adverse reaction to smallpox November 7 2003.
COVID and COVID Pneumonia; Developed pressure wound; She was due to get 2nd dose on 15Feb2021 which she did not; This spontaneous case was reported by an other caregiver (subsequently medically confirmed) and describes the occurrence of COVID-19 (COVID and COVID Pneumonia) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included METOPROLOL, DULOXETINE, CLOPIDOGREL, ACETYLSALICYLIC ACID (ASPIRIN 81), FAMOTIDINE, VITAMIN D3, CLONAZEPAM, ATORVASTATIN, CICLOSPORIN (RESTASIS), IPRATROPIUM, AIRBORNE and ASCORBIC ACID, COLECALCIFEROL, SAMBUCUS NIGRA FRUIT, TOCOPHEROL, ZINC GLUCONATE (AIRBORNE ELDERBERRY) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced COVID-19 (COVID and COVID Pneumonia) (seriousness criterion hospitalization). On an unknown date, the patient experienced DECUBITUS ULCER (Developed pressure wound) and PRODUCT DOSE OMISSION ISSUE (She was due to get 2nd dose on 15Feb2021 which she did not). The patient was hospitalized from 27-Jan-2021 to 15-Feb-2021 due to COVID-19. On 15-Feb-2021, COVID-19 (COVID and COVID Pneumonia) outcome was unknown. At the time of the report, DECUBITUS ULCER (Developed pressure wound) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (She was due to get 2nd dose on 15Feb2021 which she did not) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 07-Feb-2021, the patient experienced COVID-19 PNEUMONIA (COVID-19 pneumonia) (seriousness criterion hospitalization prolonged) which was a part of COVID infection. Treatment for the events included remdesivir, dexamethasone, antibody plasma and trimethoprim/sulfamethoxazole for the pressure wound.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/5/21 (EN6206) Pfizer Dose 2 3/25/21 (ER8732) Pfizer Dose 3 9/28/21 (FF2587) COVID Positive 2/11/21  2/11/22: 32 YR OLD MALE HX OF LONG STANDING IDDM with multiple end organ damages, blind, gastroparesis, required pancreatic and kidney transplant in 8/2020, on immuniosuppressants, Dm neuropathy, former heroin abuse, tx for Hep C 3 days of vomit mom states related to nasal congestion with post nasal drip, causing his gastroparesis to vomit up mucus. vomit has tingle blood today, epigastric/mid epigastric pain that began after midnight, now severe, ondanestron ODT not working, unable to keeping anything down. decrease urine output, but no dysuria. unsure of blood stools or hematuria but not obvious. able to take his medications.  appears to have been in our ED Sept 2021 last year with very similar issues.  2/13/22: Patient was admitted for recurrent problems where he cannot eat or drink for days due to vomiting and nausea secondary to gastroparesis and also marijuana use.  Patient states that he ate a full meal this morning and feels really good and did not have any nausea or vomiting. Patient is feeling better and is ready home med patient was COVID positive upon admission however has not had any shortness of breath or any problems due to the COVID
On 7/14/22 pt stopped by office and reported to RN that he had a seizure the evening of vaccines and went to ED. Pt offered and declined an office visit with medical provider on 7/14/2022.
Extreme headache and pain in upper back, shoulder and neck region. Stiffness and unable to move
Information has been received from a health professional concerning a 16 month old child who about one month ago, in approximately January 2006, was vaccinated with a dose of varicella virus vaccine live. Within a month of vaccination, the child developed a severe case of infected pustules on the right side of their face which was diagnosed as chickenpox. The child had to be hospitalized and was placed on ceftriaxone sodium. At the time of the report, after hospitalization, it was noted that the child was recovering. There was no product quality complaint involved. The reporter also considered the patient's chicken pox to be an other important medical event (OMIC), hospitalization required. Additional information has been requested.
Patient stated developed an area 3 inches below injection site. Measuring 5 inches x 4 inches at widest point. Patient given antibiotic and instructions to return 2/1/11. Patient was seen 1/31/11.
Varivax site - red, swollen - 6"x8" area, tender to touch, hard, blistery, itchy. Resolved about 6 days. Zyrtec given.
Received zoster vaccine on 2/6/19 and on 2/12/19 reports that she developed swelling and redness with itchiness, joint pain and N/V to the injection site and extremity in general. She did see a PCP and reported the reaction to them and was advised to no receive the second injection. To my knowledge she did not receive any treatments for the reaction. Symptoms: Symptoms: 1. SkinRash, 2. Rash, 3. UrticariaPruritus, 4. NauseaVomiting, 5. RASH, joint pain
Bells Palsy - Right sided facial paralysis with inability to fully close right eye. Treated with 1 week of 60mg prednisone, artificial eye drops, and artificial eye ointment.
Approximately 2 weeks after receiving the H1N1 vaccine the patient experienced a stiff neck (both sides), then several days/1 week later he experienced decreased hearing (low range) and tinnitis. The patient went to an ENT clinic and had documented hearing loss on audiogram. He was treated with high dose steroids and then tympanic steroids. The sensory hearing neural loss has still not resolved (01/21/10).
About one minute after shot patient became dizzy. She told me numerous times that something was wrong and and that she did not feel good. She turned a pale green color in face. She had nausea and could not stand up straight. She had to lean on rail in hallway so she would not fall. At nurses station she could not sit up in chair and had to sit on ground with head on chair. Her lips turned white. She started sweating and became very clammy. She was not able to get up so nurse helped her up and walked her by her arm to the car so she would not fall. Nurse told me that these are not usually side effects of Hep A shot and if she got worse to bring her back.
This spontaneous report as received from a healthcare worker to a patient of unknown age and gender. On an unknown date in 2013 (reported as approximately one year ago) the patient received first dose of GARDASIL (dose, route not reported). On 22-JUL-2014 the patient was at the office and would like to receive second dose of GARDASIL (dose, route not reported). No adverse symptoms reported. Additional information has been requested.
Thursday night at around 11pm I lost control of my right arm. Friday I spent the day in Urgent Care doing CT scans and MRI scans of my brain and body and also did some blood work. All test came back negative. It is now Monday the 21st and the mobility in my right arm is extremely limited and I am slowly regaining the use of my right arm.
This spontaneous report as received from a consumer refers to a 74 year old patient reporting on itself. On 28-AUG-2013, the patient was vaccinated with a dose of ZOSTAVAX for prevention of shingles (dose, route and lot # not provided). The patient reported that had shingles (approximately in 2013) when was vaccinated with ZOSTAVAX, but the patient didn't knew that had them. The patient had the vaccine and now had them again (in 2013). The outcome of shingles is unknown. Additonal information in not expected.
About 53 hours after receiving my second dose, I felt a large palpitation. I didn't think anything of it, but I fainted and fell to the floor. I had cuts in my head. During the course of my visit, the doctors told me that I had supraventricular tachycardia. I had a referral to a cardiologist. He ordered a two-week portable monitor for me. After that, I saw another doctor, who is an interventional cardiologist. He noticed that I had SVT. He recommended that I have an internal monitor. I have a telephone beside my bed that records my heart rhythm at night. If I have a feeling during the day, I can push a button and it will point out the time that I felt it to the doctor that is viewing my results. I was switched from losartan and now I'm taking metoprolol and flecainide 50mg 2x per day. While in the hospital, I was under 24-hour observation.
In my first menstrual cycle following my second dose of the Pfizer COVID-19 vaccine (2nd dose received 09/09/2021), I experienced extremely heavy and protracted menstrual bleeding.  This began Sept 19th and continuing through Sept 24th 2021.    My periods normally last about 3-4 days with moderate fluid flow and are very regular/predictable.  During this September menstrual cycle however my period lasted 6 days with a very heavy flow that I would estimate to be twice the volume of blood/fluids as is typical for me.  It was of special concern to me since I am working with my doctors on overcoming a chronic low iron condition and am concerned about losing too much iron.  Since the Sept menstrual cycle I have had one additional menstrual cycle, occurring Oct 14th through Oct 17th.  The length of the cycle was of a more normal range at 4 days total.  The flow was still heavier than typical but less heavy than my cycle in September and closer to normal.  Hoping the residual heaviness side effect is transitory, returning to normal volume in the coming months.  Also of note, 2 days after my first Pfizer vaccine dose (1st dose received 7/15/2021), on July 17th, I developed a noticeable bruise along the left portion of my upper lip.  I had not injured my lip/mouth in any way that I could recall, and so attributed it to some sort of visible clotting indicator showing through in the thin skin there.  I took low-dose aspirin for the next week, at which time the bruise went away.
Patient presented with pain and swelling at injection site the day after receiving PNEUMOVAX. Her physician prescribed Prednisone and KEFLEX for the reaction.
neck and arm glands were inflamed; had swollen lymph node on the left side of his neck; This is a spontaneous report from a contactable consumer. A 50-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date in Apr2021 (at the age of 50-year-old)(Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included ongoing rheumatoid arthritis. Concomitant medication included etanercept (ENBREL, Solution for injection in pre-filled syringe, lot number: 1125680, expiry date: 31Aug2023) taken for rheumatoid arthritis, start and stop date were not reported. On an unknown date in 2021, the patient stated his neck and arm glands were inflamed, when he was vaccinated with COVID-19 vaccine early this year and resolved. It was further reported on an unknown date in 2021, the patient had swollen lymph node on the left side of his neck. The event outcome was recovered in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Initially noticed <5 small maculo-papular vs. vesicular lesions on forehead, these spread to behind ears, down her face to neck and then trunk and entire body.  They were not extremely erythematous.  Temperature was not taken but felt febrile, was fatigued, fussy, and sleepy.
Re-started period after not having it since 2014 b/c of IUD. Avid runner, had to have someone pick me up while on a run because the pain was so bad. Nearly fainted. Period stayed for a few days. Cycled through with a period the next month, too, before not having it again since.
Pt recv vax on 9/9/98; on same day pt exp nausea, dry heaves, lightheaded, achiness, dizzy, chills&weakness for 2 day.
This spontaneous report was received from a 24 year old female pharmacist reporting on herself. Pertinent medical history and drug reactions or allergies were not reported. At the time of the report the pharmacist was not pregnant. On 15-JAN-2015 the pharmacist experienced accidental exposure to product, described as she was exposed to ZOSTAVAX 19400 PFU suspension (lot number K018173, expiry date reported as 10-JAN-2016) on the skin around her left eye and possibly in her left eye, during the administration of the ZOSTAVAX to a consumer. Concomitant medication included Niastrin. On the same date the pharmacist experienced vision blurred (described as blurriness) in her left eye which resolved the same day. It was reported that this event was treated with an eye wash with water on left eye and the skin around the left eye was washed with soap and water. There were no lab diagnostics studies performed. It was reported that the pharmacist did not seek medical attention and no disability, incapacity or hospitalization were reported. There was no product quality complaint involved. The reporter did not rate the relatedness between ZOSTAVAX and vision blurred. This is one of two reports received from the same source. Additional information has been requested.
Temporal thermometer reading got up to 105 F, brought down to 102.9 with Tylenol(1,000 mg taken) along with tepid bath and pushing cool oral fluids, headache lasting throughout day making sensitivity to light and noise without being dizzy. ibuprofen taking q6 to help with headache.
This spontaneous report was received from a registered nurse refers to an adult patient of unknown gender and unknown age. The registered nurse reports that on 28-JAN-2013, she administered to the patient (Merck) PROQUAD instead of separate dose of MMRII and (Merck) VARIVAX. The registered nurse stated that this was an  staff error only. No other co-suspects were reported. No concomitant medications were reported. No treatment information was reported. The outcome for the patient events is unknown. Additional information is not expected.
Incoherent, unstable, difficult to talk, confusion, felt distant (isolation) from others in the room, weak, dry mouth and throat, queasy. I drove home 1-2 hours later when feeling a little better and had to really focus to get myself home, difficult to recognize the area around me when driving. It was difficult to do anything when arriving home, went to bed. I was better the next morning (today) but my brain is still fogged.
30Sep89 pt vax w/ 2nd hepta B; 05Oct89 devel lower abdo cramps, D/, excessive flatulence + rectal mucorrhea. Tx w/ bland diet, Imodium, Pepto-Bismol. Exp inject site pain after 14 days.
spacey feeling out of it; moderate to severe body aches; Fatigue; low fever; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8737) via an unspecified route of administration in the left arm on 05Apr2021 at 12:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, thyroid cancer and blood clotting disorder. Concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 15:00, the patient experienced fatigue, moderate to severe body aches, low fever and spacey feeling out of it(spaced out). The patient did not receive any treatment for the reported events. The clinical outcome of the events fatigue, moderate to severe body aches, low fever and spacey feeling out of it was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
MVP/stabbing pain, Fog/vision blurred, Disorientation of whereabouts to drive home from Doctors office, Nausea-severe, Low grade temp-6weeks endurance, Yeast infection,  Shortness of breath/wheezing
This spontaneous report as received from a medical assistant refers to unspecified number of patients of unknown age and gender. The reporter stated that GARDASIL was improperly stored and administered (dose, units, anatomical location, route of administration, lot number were not reported) to unspecified number of patients on unspecified dates. This is one of several reports from the same reporter. Additional information has been requested.
First COVID vaccine given 2/11/2021, second dose covid vaccine given 3/10/2021. Person was exposed to a COVID person. On 7/23/2021 experienced sinus congestion.  Tested positive for COVID on 7/26/2021. Received Monoclonal antibody treatment on 7/26/2021.